drugset / Trial / NCT01009931
Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies
Phase 2
Terminated
1 enrolled
Rutgers, The State University of New Jersey
Biosuccess Biotech Co., Ltd. · collabNational Cancer Institute (NCI) · collabRutgers Cancer Institute of New Jersey · collab
NaSingle-groupOpen-labelTreatment
Summary
This phase II trial is studying the side effects and how well giving tetradecanoylphorbol acetate together with dexamethasone and choline magnesium trisalicylate works in treating patients with relapsed or refractory acute myeloid leukemia.
Timeline
- Start
- 2011-03
- Primary completion
- 2011-10
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 12-O-tetradecanoylphorbol-13-acetate | Unknown | 1 mg | — |
| Subject | Dexamethasone | Small molecule | 10 mg | Oral |
| Subject | choline magnesium trisalicylate | Unknown | 1500 mg | Oral |